CV of Alberta Bergamo

CV of Alberta BergamoAlberta BergamoChemist and Technological PharmacistE‐mail:a.bergamo@c allerio.org ‐ abergamo@units.itTel: 040 – 558 8639AREA OF INTEREST: Pharmacology , Cancer Therapy, PharmacogenomicsFIELDS OF RESEARCH:‣ Pharmacological evaluation of metal‐based compounds active on metastases of solidtumours;‣ Investigation of metastatatic progression mechanisms at cellular and molecular level;‣ Set up of novel in vitro tumour models alternative to animal use;‣ Identification of tumour targets for the selective control of metastasis growth;‣ Pharmacological evaluation of metal‐based compound as potential photosensitizers inthe Photodynamic Therapy.TEACHING ACTIVITY:‣ Teacher of “Basis of Pharmacogenetics and Pharmacogenomics” in the Master DegreeCourse in “Functional Genomics” at the University of Trieste;‣ Tutoring activity in the preparation of degree thesis, PhD thesis, and in projectsinvolving visiting students and post‐doc researches.OTHER:‣ Leader and responsible of the Working Group “Protein Targets” within the COSTAction CM1105;‣ Member of the Italian Society of Pharmacology (SIF);‣ Member of the Italian Society of Chemotherapy (SIC);‣ Collaborator in the management of the SIC website.SELECTED PAPERS OF THE LAST 3 YEARS:‣ Gianferrara T, Bergamo A, Bratsos I, Milani B, Spagnul C, Sava G, Alessio E. Rutheniumphorphyrinconjugates with cytotoxic and phototoxic antitumor activity. J Med Chem,53: 4678‐904, 2010.‣ Alberta Bergamo and Gianni Sava. Ruthenium anticancer compounds: mythsand realities of the emerging metal‐based drugs. Dalton Trans, 40: 7817‐23, 2011.‣ Sava G, Bergamo A, Dyson PJ. Metal‐based antitumour drugs in the postgenomicera: what comes next? Dalton Trans, 40: 9069‐75, 2011.